Insilico Medicine Kicks off Clinical Trial for its Fully AI-Discovered Drug

Hong Kong-headquartered AI-driven drug discovery startup Insilico Medicine said Friday that it has dosed 80 healthy volunteers in a Phase I clinical trial to evaluate the safety of a drug candidate generated by the company’s AI-powered drug discovery platform to cure idiopathic pulmonary fibrosis

Read more:


在 建立網站或網誌

向上 ↑

%d 位部落客按了讚: